Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
George Church spinout restructures, considers strategic options
Big-shot academic origin, a star roster of investors and the proximity of a financing round render GRObio’s slip into uncertainty puzzling.
Angus Liu
Mar 13, 2025 2:00pm
US biotech finds Relief via reverse merger
Nov 4, 2024 1:05pm
MEI, after failed Infinity merger last year, faces its end
Jul 22, 2024 10:00am
Ikena cuts Hippo med, half of staff in latest reprioritization
May 29, 2024 9:15am
LianBio lays off half of workforce as biotech winds down
Feb 13, 2024 9:10am
Windtree's search for help shifts to full company sale
Jan 31, 2024 10:35am
